Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: a single-institution study.
We report on our experience in the treatment of intracranial germinomas (18 pure germinomas and two germinomas with syncytiotrophoblastic giant cells) according to a strategy of radiotherapy doses and fields reduction after a neoadjuvant chemotherapy (Cisplatin-vinblastine and bleomycin combination). Radiation therapy was delivered after the completion of the third and last course of chemotherapy. For the solitary germinoma the target volume was the gross tumour volume. In the five multifocal germinoma patients the whole ventricle volume was irradiated. For the single disseminated germinoma patient we treated the whole central nervous system. The cumulative doses were 30 Gy for the pure germinomas. For the STGCs, a cumulative dose of 35 Gy was used. The median follow-up was 55 months (range 12-120). 18 patients were alive without recurrence of disease. In the two patients with STGCs the death took place 16 and 35 months after diagnosis.
Silvani
Antonio
A
Department of Neuro-Oncology, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy. silvani@istituto-besta.it
Eoli
Marica
M
Salmaggi
Andrea
A
Lamperti
Elena
E
Fariselli
Laura
L
Milanesi
Ida
I
Broggi
Giovanni
G
Solero
Carlo Lazzaro
CL
Giombini
Sergio
S
Boiardi
Amerigo
A
D000293:Adolescent; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D017024:Chemotherapy, Adjuvant / Q000379:methods; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy / Q000379:methods; D005260:Female; D018237:Germinoma / Q000188:drug therapy* / Q000532:radiotherapy*; D005870:Giant Cell Tumors / Q000188:drug therapy / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010870:Pineal Gland / Q000473:pathology; D011829:Radiation Dosage; D016019:Survival Analysis; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; D014747:Vinblastine; D002945:Cisplatin
J Neurosurg. 1998 Jan;88(1):66-72
9420074
Funct Neurol. 1987 Apr-Jun;2(2):189-94
3666548
J Neurosurg. 2002 Jun;96(6):1020-2
12066901
J Neurol Neurosurg Psychiatry. 1999 Sep;67(3):358-63
10449559
J Clin Oncol. 2002 Feb 1;20(3):857-65
11821471
Klin Padiatr. 1997 Jul-Aug;209(4):222-7
9293454
J Neurosurg. 1997 Aug;87(2):262-6
9254091
J Clin Oncol. 1990 Jul;8(7):1277-80
2358840
J Neurosurg. 2000 Aug;93(2):245-53
10930010
J Clin Oncol. 1991 Mar;9(3):400-5
1999710
Oncologist. 2000;5(4):312-20
10964999
Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):783-8
10098433
No Shinkei Geka. 2002 Sep;30(9):935-42
12233091
Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):505-10
9112445
Cancer. 1994 Aug 1;74(3):940-4
8039122
Radiology. 2001 Feb;218(2):452-6
11161161
J Neurosurg. 1997 Mar;86(3):446-55
9046301
Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):511-5
9112446
Singapore Med J. 2002 Apr;43(4):182-8
12188062
Int J Radiat Oncol Biol Phys. 1997 Jul 15;38(5):915-23
9276355
Acta Neurochir (Wien). 1991;109(1-2):78-83
2068974
Gan No Rinsho. 1986 Sep;32(11):1387-93
2430119
Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):511-8
12738328
J Clin Oncol. 1996 Nov;14(11):2908-15
8918487
J Neurosurg. 1989 May;70(5):707-13
2709111
Int J Radiat Oncol Biol Phys. 1990 Aug;19(2):429-33
2394620
Curr Treat Options Neurol. 2002 Mar;4(2):139-145
11827646
Br J Cancer. 1994 Nov;70(5):984-9
7947108
Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1171-6
10725628